Proactive

Proactive

Broadcast Media Production and Distribution

London, London 22,798 followers

Proactive leads the world in up-to-the-minute breaking news, CEO interviews and market summaries on smaller companies

About us

Proactive enables companies and investors to connect intelligently. We are one of the fastest growing financial media portals in the world, providing breaking news, commentary and analysis on hundreds of listed companies and pre-IPO businesses across the globe, 24/7. And, uniquely, our renowned multi-media business is complemented by quality events management, smart investor relations delivery and a highly respected research offering. Quite simply, we exist to unite companies with investors. We are first to market in delivering accurate, authoritative content provided by recognised leading journalists and industry experts - enabling the investor community to gain access to rich, dynamic, relevant information about client businesses. We target only the most engaged investor audiences, amplifying, illuminating and marshalling the facts to ensure that we meet every client’s objectives. And then we support our clients with accurately focused investor events, dynamic investor relations and meticulous research.

Website
http://www.proactiveinvestors.co.uk
Industry
Broadcast Media Production and Distribution
Company size
51-200 employees
Headquarters
London, London
Type
Privately Held
Founded
2006
Specialties
Media, Financial News, Events, Social Media, Financial Journalism, Investments, Stockmarket, News, Investor Relations, stocks, cryptocurrency, binance, Financial News, NASDAQ, BLOOMBERG, NYSE, CSE, LONDON Stock Exchange, LSE, Investing, Investor News, Money, and Technology

Locations

Employees at Proactive

Updates

  • Prescient Therapeutics jumped as much as 53.7% this morning after receiving a green light from the US FDA to proceed with its Phase 2 clinical trial of PTX-100 — the company’s first-in-class Ras pathway inhibitor.  The FDA cleared the Investigational New Drug (IND) application for the Phase 2 trial 100 — a significant milestone for Prescient — paving the way for the commencement of the Phase 2 study which will focus on relapsed and refractory cutaneous T-cell lymphomas (r/r CTCL).  The planned Phase 2 study builds on compelling Phase 1b data that demonstrated PTX-100’s potential to address key unmet medical needs in T-cell lymphomas (TCL), including r/r CTCL.  More at #Proactive #ProactiveInvestors #Prescient #CTCL #ASX #PTX #PSTTF #ASXbiotech #lymphomas #Tcell http://ow.ly/j8rS105SkYf

    Prescient Therapeutics welcomes US FDA allowance of Investigational New Drug application for PTX-100 Phase 2 clinical trial

    Prescient Therapeutics welcomes US FDA allowance of Investigational New Drug application for PTX-100 Phase 2 clinical trial

    proactiveinvestors.com.au

  • Wedgemount Resources Corp (CSE:WDGY, OTCQB:WDGRF) CEO Mark Vanry joined Proactive to discuss significant achievements from the company in 2024 and its outlook for the New Year. He highlighted the Huggy acquisition, which has quadrupled Wedgemount’s operational scale. Proactive: The company recently issued a news release highlighting 2024 milestones and looking ahead to 2025. Let’s start with west-central Texas and your oil and gas assets there. What’s happening in that region? Mark Vanry: In August, we made our largest acquisition to date: the Huggy acquisition. It quadrupled the size of our company. Since closing that deal, our focus has been on optimizing... http://ow.ly/z6bh105SgLs

    • No alternative text description for this image
  • Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF) CEO Corey Ruttan talked with Proactive about the company’s 2024 performance and strategic goals. Ruttan detailed the company’s November production numbers, which reflected seasonal maintenance by both Alvopetro and its gas consumers. This led to a temporary dip, but December’s production rebounded significantly, increasing by 43%. Proactive: Let’s start with November. You've updated your sales numbers. There were some interesting numbers in there. Corey Ruttan: Yes, we announce our production monthly. November was a bit lower. In the state where we produce gas, November is typically a time for facility maintenance... http://ow.ly/FFYB105Sgyy

    • No alternative text description for this image
  • First Phosphate Corp. (CSE:PHOS, OTCQB:FRSPF) earlier this week announced key developments that strengthen its position as a resource developer. The company signed offtake agreements for upstream phosphate processing, which it said enhance the financial viability of its operations and pave the way for future feasibility studies. CEO John Passalacqua highlighted the agreements as a significant achievement for the company’s size and stage of development, crediting the quality of its Preliminary Economic Assessment (PEA) and resources at Bégin-Lamarche. The company also announced progress in its collaboration with First Nations partners. It signed an agreement... http://ow.ly/ejHA105SghH

    • No alternative text description for this image
  • NEXE Innovations Inc (TSX-V:NEXE, OTC:NEXNF) president Ash Guglani talked with Proactive about the company’s growing partnership with EKOCUPS, a major US-based Amazon seller. He emphasized that this collaboration marks a significant step for Nexe as it strengthens its recurring revenue in the US coffee capsule market. Proactive: So, another news release from the company today talking about more recurring business. As far as this company called EKOCUPS that we've talked about in the past—this is really the pathway for the company into the US. Ash Guglani: Yeah, absolutely. Look, I mean, we have a good growing relationship with EKOCUPS know, they're giving us... http://ow.ly/zLB4105SgeA

    • No alternative text description for this image
  • Zero Candida Ltd (TSX-V:ZCT) is at the forefront of biotech innovation, addressing the growing need for effective solutions to combat fungal infections. In this Q&A, CEO Eli Ben Haroosh discusses their strategic vision, the technology driving their mission, and the market potential of their advancements in Candida treatment. Proactive: We’re going to talk about your company securing a patent in South Africa. But before we dive into that, can you tell us a bit more about Zero Candida and the work you’re doing? Eli Ben Haroosh: Of course. Our team has been doing amazing work. We’ve had a PhD consultant working with us for over five years, helping us develop and... http://ow.ly/2Fou105SfXi

    • No alternative text description for this image
  • EnWave Corp (TSX-V:ENW, OTC:NWVCF) CEO Brent Charleton spoke with Proactive about the company’s recent strides, including a partnership with ELEA Technology to develop healthier snacks, a strong rebound in 2024 financial performance, and a key board appointment. Charleton shared how these advancements, alongside EnWave’s patented REV drying technology, are shaping the company’s growth strategy for 2025 and beyond. Proactive: There’s been a lot of news over the last few days. First, you've announced a partnership with ELEA Technology. This is for healthier snacks. Tell me about how this came about. Brent Charleton: We previously explored combining their... http://ow.ly/iI2P105SbM0

    • No alternative text description for this image
  • Arizona Gold & Silver Inc (TSX-V:AZS, OTCQB:AZASF) CEO Mike Stark joined Proactive to discuss the company’s latest drill results from two key sites at its Philadelphia gold-silver project in Arizona, Red Hills and Rising Fawn. He highlighted that the drill holes at Red Hills have exceeded expectations with larger-than-anticipated widths, and geologists are optimistic about the findings at Rising Fawn. Proactive: Last time you and I chatted, you were on site witnessing the beginning of your drill program. Let’s start by talking about the two areas you’re focusing on in this program. Mike Stark: Very interesting areas. We’re extremely pleased right now. Two... http://ow.ly/ucrJ105Sfx1

    • No alternative text description for this image
  • European Green Transition's chief explains why its ambitions are broader than rare earths - ICYMI @EuropeanGreenT #AIM #EGT. European Green Transition PLC (AIM:EGT) chief executive Aiden Lavelle talks through the latest Olserum drill results and plans beyond exploring for rare earths. Aiden Lavelle: We've announced the results for another five holes [at Olserum] which makes a total of 13 across the Olserum West and Djupedal prospects at the project in South Sweden. And, again, all five holes that we announced this morning have hit mineralisation. We had two very good intersections. One of the holes at Djupedal intercepted 2.45m grading 2.71% total rare earth... http://ow.ly/v9V3105Sfj9

  • Giyani Metals CEO on progress at Johannesburg demo plant - ICYMI @GiyaniMetals #TSXV #OTC #EMM #CATPF. Giyani Metals Corp (TSX-V:EMM, OTC:CATPF) CEO Charles FitzRoy talked with Proactive about the commissioning progress of their demonstration plant in Johannesburg. While the company targets first production of high-purity manganese sulfate monohydrate this year, unforeseen setbacks like power and water outages have caused potential delays into early Q1. FitzRoy highlighted the plant's role in de-risking the main facility planned for Botswana and noted minor adjustments that improve operational insights. Proactive: Charlie, very good to speak with you. You're... http://ow.ly/EM91105Sfbx

Similar pages

Browse jobs

Funding

Proactive 3 total rounds

Last Round

Series C

US$ 3.2M

See more info on crunchbase